Advertisement

Ads Placeholder
Loading...

Virbac SA

VRBCF•PNK
Healthcare
Drug Manufacturers - General
$384.75
$0.00(0.00%)
U.S. Market is Open • 15:37

Virbac SA (VRBCF) Stock Overview

Explore Virbac SA’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.2B
P/E Ratio18.62
EPS (TTM)$20.70
ROE0.14%
Fundamental Analysis

AI Price Forecasts

1 Month$350.76
3 Months$349.82
1 Year Target$346.74

VRBCF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Virbac SA (VRBCF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 58.72, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $346.74.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 18.62 and a market capitalization of 3.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
11.20%
3-Month Change
11.20%
6-Month Change
11.20%
Year-to-Date (YTD) Change
11.20%
1-Year Change
18.75%
3-Year Change
-3.81%
5-Year Change
52.38%
All-Time (Max) Change
451.61%

Contact Information

https://corporate.virbac.com
33 4 92 08 71 00
13e rue LID - BP 27, Carros, NaN, 06511

Company Facts

63,650 Employees
IPO DateApr 17, 2013
CountryFR
Actively Trading

Frequently Asked Questions